The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

Age related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

Age-related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...

The research team from the Natural Product Drug Development Center at the Korea Institute of Science and Technology has developed a new therapeutic agent for dry Age-related macular ...

The Korea Institute of Science and Technology (KIST) announced on the 18th that it held a signing ceremony for technology ...

may be an advanced form of macular degeneration, or loss of vision. Geographic atrophy, also known as GA, is a form of advanced dry macular degeneration where patients can develop vision loss from ...

may be an advanced form of macular degeneration, or loss of vision. Geographic atrophy, also known as GA, is a form of advanced dry macular degeneration where patients can develop vision loss from ...

Like dry AMD, this type doesn't affect peripheral ... In evaluating data from 17,100 people with advanced macular degeneration, genetic researchers linked at least 19 genes to an increased risk ...

Macular degeneration is a prevalent eye disorder that typically results in loss of vision in individuals who are 50 years of age and older. Although there isn’t a recognized cure for this ...